CymaBay Therapeutics, Inc.
Treatment of cholangiopathies
Last updated:
Abstract:
Seladelpar and its salts are useful in the treatment of cholangiopathies in subjects who are intolerant of, or have an inadequate response to, obeticholic acid and/or fibrates.
Status:
Application
Type:
Utility
Filling date:
29 Jan 2022
Issue date:
4 Aug 2022